Pathogenic Gut Flora in Patients With Chronic Heart Failure

Evasio Pasini, Roberto Aquilani, Cristian Testa, Paola Baiardi, Stefania Angioletti, Federica Boschi, Manuela Verri, Francesco Dioguardi

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Objectives: The goal of this study was to measure the presence of pathogenic gut flora and intestinal permeability (IP) and their correlations with disease severity, venous blood congestion, and inflammation in patients with chronic heart failure (CHF). Background: Evidence suggests that translocation of gut flora and/or their toxins from the intestine to the bloodstream is a possible trigger of systemic CHF inflammation. However, the relation between pathogenic gut flora and CHF severity, as well as IP, venous blood congestion as right atrial pressure (RAP), and/or systemic inflammation (C-reactive protein [CRP]), is still unknown. Methods: This study analyzed 60 well-nourished patients in stable condition with mild CHF (New York Heart Association [NYHA] functional class I to II; n = 30) and moderate to severe CHF (NYHA functional class III to IV; n = 30) and matched healthy control subjects (n = 20). In all subjects, the presence and development in the feces of bacteria and fungi (Candida species) were measured; IP according to cellobiose sugar test results was documented. The study data were then correlated with RAP (echocardiography) and systemic inflammation. Results: Compared with normal control subjects, the entire CHF population had massive quantities of pathogenic bacteria and Candida such as Campylobacter (85.3 ± 3.7 CFU/ml vs. 1.0 ± 0.3 CFU/ml; p <0.001), Shigella (38.9 ± 12.3 CFU/ml vs. 1.6 ± 0.2 CFU/ml; p <0.001), Salmonella (31.3 ± 9.1 CFU/ml vs 0 CFU/ml; p <0.001), Yersinia enterocolitica (22.9 ± 6.3 CFU/ml vs. 0 CFU/ml; p <0.0001), and Candida species (21.3 ± 1.6 CFU/ml vs. 0.8 ± 0.4 CFU/ml; p <0.001); altered IP (10.2 ± 1.2 mg vs. 1.5 ± 0.8 mg; p <0.001); and increased RAP (12.6 ± 0.6 mm Hg) and inflammation (12.5 ± 0.6 mg/dl). These variables were more pronounced in patients with moderate to severe NYHA functional classes than in patients with the mild NYHA functional class. Notably, IP, RAP, and CRP were mutually interrelated (IP vs. RAP, r = 0.55; p <0.0001; IP vs. CRP, r = 0.78; p <0.0001; and RAP vs. CRP, r = 0.78; p <0.0001). Conclusions: This study showed that patients with CHF may have intestinal overgrowth of pathogenic bacteria and Candida species and increased IP associated with clinical disease severity, venous blood congestion, and inflammation.

Original languageEnglish
Pages (from-to)220-227
Number of pages8
JournalJACC: Heart Failure
Volume4
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Atrial Pressure
Permeability
Heart Failure
Inflammation
Candida
C-Reactive Protein
Hyperemia
Bacteria
Cellobiose
Yersinia enterocolitica
Shigella
Campylobacter
Gastrointestinal Microbiome
Feces
Salmonella
Intestines
Echocardiography
Healthy Volunteers
Fungi
Population

Keywords

  • Chronic heart failure
  • Gut flora
  • Inflammation
  • Intestinal permeability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pasini, E., Aquilani, R., Testa, C., Baiardi, P., Angioletti, S., Boschi, F., ... Dioguardi, F. (2016). Pathogenic Gut Flora in Patients With Chronic Heart Failure. JACC: Heart Failure, 4(3), 220-227. https://doi.org/10.1016/j.jchf.2015.10.009

Pathogenic Gut Flora in Patients With Chronic Heart Failure. / Pasini, Evasio; Aquilani, Roberto; Testa, Cristian; Baiardi, Paola; Angioletti, Stefania; Boschi, Federica; Verri, Manuela; Dioguardi, Francesco.

In: JACC: Heart Failure, Vol. 4, No. 3, 01.03.2016, p. 220-227.

Research output: Contribution to journalArticle

Pasini, E, Aquilani, R, Testa, C, Baiardi, P, Angioletti, S, Boschi, F, Verri, M & Dioguardi, F 2016, 'Pathogenic Gut Flora in Patients With Chronic Heart Failure', JACC: Heart Failure, vol. 4, no. 3, pp. 220-227. https://doi.org/10.1016/j.jchf.2015.10.009
Pasini, Evasio ; Aquilani, Roberto ; Testa, Cristian ; Baiardi, Paola ; Angioletti, Stefania ; Boschi, Federica ; Verri, Manuela ; Dioguardi, Francesco. / Pathogenic Gut Flora in Patients With Chronic Heart Failure. In: JACC: Heart Failure. 2016 ; Vol. 4, No. 3. pp. 220-227.
@article{4b724afff27d493485ea2f795f025a7e,
title = "Pathogenic Gut Flora in Patients With Chronic Heart Failure",
abstract = "Objectives: The goal of this study was to measure the presence of pathogenic gut flora and intestinal permeability (IP) and their correlations with disease severity, venous blood congestion, and inflammation in patients with chronic heart failure (CHF). Background: Evidence suggests that translocation of gut flora and/or their toxins from the intestine to the bloodstream is a possible trigger of systemic CHF inflammation. However, the relation between pathogenic gut flora and CHF severity, as well as IP, venous blood congestion as right atrial pressure (RAP), and/or systemic inflammation (C-reactive protein [CRP]), is still unknown. Methods: This study analyzed 60 well-nourished patients in stable condition with mild CHF (New York Heart Association [NYHA] functional class I to II; n = 30) and moderate to severe CHF (NYHA functional class III to IV; n = 30) and matched healthy control subjects (n = 20). In all subjects, the presence and development in the feces of bacteria and fungi (Candida species) were measured; IP according to cellobiose sugar test results was documented. The study data were then correlated with RAP (echocardiography) and systemic inflammation. Results: Compared with normal control subjects, the entire CHF population had massive quantities of pathogenic bacteria and Candida such as Campylobacter (85.3 ± 3.7 CFU/ml vs. 1.0 ± 0.3 CFU/ml; p <0.001), Shigella (38.9 ± 12.3 CFU/ml vs. 1.6 ± 0.2 CFU/ml; p <0.001), Salmonella (31.3 ± 9.1 CFU/ml vs 0 CFU/ml; p <0.001), Yersinia enterocolitica (22.9 ± 6.3 CFU/ml vs. 0 CFU/ml; p <0.0001), and Candida species (21.3 ± 1.6 CFU/ml vs. 0.8 ± 0.4 CFU/ml; p <0.001); altered IP (10.2 ± 1.2 mg vs. 1.5 ± 0.8 mg; p <0.001); and increased RAP (12.6 ± 0.6 mm Hg) and inflammation (12.5 ± 0.6 mg/dl). These variables were more pronounced in patients with moderate to severe NYHA functional classes than in patients with the mild NYHA functional class. Notably, IP, RAP, and CRP were mutually interrelated (IP vs. RAP, r = 0.55; p <0.0001; IP vs. CRP, r = 0.78; p <0.0001; and RAP vs. CRP, r = 0.78; p <0.0001). Conclusions: This study showed that patients with CHF may have intestinal overgrowth of pathogenic bacteria and Candida species and increased IP associated with clinical disease severity, venous blood congestion, and inflammation.",
keywords = "Chronic heart failure, Gut flora, Inflammation, Intestinal permeability",
author = "Evasio Pasini and Roberto Aquilani and Cristian Testa and Paola Baiardi and Stefania Angioletti and Federica Boschi and Manuela Verri and Francesco Dioguardi",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.jchf.2015.10.009",
language = "English",
volume = "4",
pages = "220--227",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Pathogenic Gut Flora in Patients With Chronic Heart Failure

AU - Pasini, Evasio

AU - Aquilani, Roberto

AU - Testa, Cristian

AU - Baiardi, Paola

AU - Angioletti, Stefania

AU - Boschi, Federica

AU - Verri, Manuela

AU - Dioguardi, Francesco

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objectives: The goal of this study was to measure the presence of pathogenic gut flora and intestinal permeability (IP) and their correlations with disease severity, venous blood congestion, and inflammation in patients with chronic heart failure (CHF). Background: Evidence suggests that translocation of gut flora and/or their toxins from the intestine to the bloodstream is a possible trigger of systemic CHF inflammation. However, the relation between pathogenic gut flora and CHF severity, as well as IP, venous blood congestion as right atrial pressure (RAP), and/or systemic inflammation (C-reactive protein [CRP]), is still unknown. Methods: This study analyzed 60 well-nourished patients in stable condition with mild CHF (New York Heart Association [NYHA] functional class I to II; n = 30) and moderate to severe CHF (NYHA functional class III to IV; n = 30) and matched healthy control subjects (n = 20). In all subjects, the presence and development in the feces of bacteria and fungi (Candida species) were measured; IP according to cellobiose sugar test results was documented. The study data were then correlated with RAP (echocardiography) and systemic inflammation. Results: Compared with normal control subjects, the entire CHF population had massive quantities of pathogenic bacteria and Candida such as Campylobacter (85.3 ± 3.7 CFU/ml vs. 1.0 ± 0.3 CFU/ml; p <0.001), Shigella (38.9 ± 12.3 CFU/ml vs. 1.6 ± 0.2 CFU/ml; p <0.001), Salmonella (31.3 ± 9.1 CFU/ml vs 0 CFU/ml; p <0.001), Yersinia enterocolitica (22.9 ± 6.3 CFU/ml vs. 0 CFU/ml; p <0.0001), and Candida species (21.3 ± 1.6 CFU/ml vs. 0.8 ± 0.4 CFU/ml; p <0.001); altered IP (10.2 ± 1.2 mg vs. 1.5 ± 0.8 mg; p <0.001); and increased RAP (12.6 ± 0.6 mm Hg) and inflammation (12.5 ± 0.6 mg/dl). These variables were more pronounced in patients with moderate to severe NYHA functional classes than in patients with the mild NYHA functional class. Notably, IP, RAP, and CRP were mutually interrelated (IP vs. RAP, r = 0.55; p <0.0001; IP vs. CRP, r = 0.78; p <0.0001; and RAP vs. CRP, r = 0.78; p <0.0001). Conclusions: This study showed that patients with CHF may have intestinal overgrowth of pathogenic bacteria and Candida species and increased IP associated with clinical disease severity, venous blood congestion, and inflammation.

AB - Objectives: The goal of this study was to measure the presence of pathogenic gut flora and intestinal permeability (IP) and their correlations with disease severity, venous blood congestion, and inflammation in patients with chronic heart failure (CHF). Background: Evidence suggests that translocation of gut flora and/or their toxins from the intestine to the bloodstream is a possible trigger of systemic CHF inflammation. However, the relation between pathogenic gut flora and CHF severity, as well as IP, venous blood congestion as right atrial pressure (RAP), and/or systemic inflammation (C-reactive protein [CRP]), is still unknown. Methods: This study analyzed 60 well-nourished patients in stable condition with mild CHF (New York Heart Association [NYHA] functional class I to II; n = 30) and moderate to severe CHF (NYHA functional class III to IV; n = 30) and matched healthy control subjects (n = 20). In all subjects, the presence and development in the feces of bacteria and fungi (Candida species) were measured; IP according to cellobiose sugar test results was documented. The study data were then correlated with RAP (echocardiography) and systemic inflammation. Results: Compared with normal control subjects, the entire CHF population had massive quantities of pathogenic bacteria and Candida such as Campylobacter (85.3 ± 3.7 CFU/ml vs. 1.0 ± 0.3 CFU/ml; p <0.001), Shigella (38.9 ± 12.3 CFU/ml vs. 1.6 ± 0.2 CFU/ml; p <0.001), Salmonella (31.3 ± 9.1 CFU/ml vs 0 CFU/ml; p <0.001), Yersinia enterocolitica (22.9 ± 6.3 CFU/ml vs. 0 CFU/ml; p <0.0001), and Candida species (21.3 ± 1.6 CFU/ml vs. 0.8 ± 0.4 CFU/ml; p <0.001); altered IP (10.2 ± 1.2 mg vs. 1.5 ± 0.8 mg; p <0.001); and increased RAP (12.6 ± 0.6 mm Hg) and inflammation (12.5 ± 0.6 mg/dl). These variables were more pronounced in patients with moderate to severe NYHA functional classes than in patients with the mild NYHA functional class. Notably, IP, RAP, and CRP were mutually interrelated (IP vs. RAP, r = 0.55; p <0.0001; IP vs. CRP, r = 0.78; p <0.0001; and RAP vs. CRP, r = 0.78; p <0.0001). Conclusions: This study showed that patients with CHF may have intestinal overgrowth of pathogenic bacteria and Candida species and increased IP associated with clinical disease severity, venous blood congestion, and inflammation.

KW - Chronic heart failure

KW - Gut flora

KW - Inflammation

KW - Intestinal permeability

UR - http://www.scopus.com/inward/record.url?scp=84959082239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959082239&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2015.10.009

DO - 10.1016/j.jchf.2015.10.009

M3 - Article

VL - 4

SP - 220

EP - 227

JO - JACC: Heart Failure

JF - JACC: Heart Failure

SN - 2213-1779

IS - 3

ER -